Dec 4, 2024 · Carfilzomib (Kyprolis) is a type of chemotherapy drug called a proteasome inhibitor. It is used alone or in combination with other medications to treat a blood cancer called multiple …

Carfilzomib, sold under the brand name Kyprolis, is an anti-cancer medication acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of …

This page contains brief information about carfilzomib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Aug 1, 2025 · Carfilzomib injection is used alone to treat relapsed (cancer that has come back) or refractory (cancer that did not respond to treatment) multiple myeloma (a type of bone marrow …

Medscape - Multiple myeloma dosing for Kyprolis (carfilzomib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost …

Carfilzomib injection is used alone and in combination with other medications to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with …

Oct 6, 2024 · Find patient medical information for Kyprolis (carfilzomib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Dec 12, 2022 · Carfilzomib Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, …

What is this medication? CARFILZOMIB (kar FILZ oh mib) treats multiple myeloma, a type of bone marrow cancer. It works by blocking a protein that causes cancer cells to grow and …

Carfilzomib is a proteasome inhibitor used either alone or in conjunction with a chemotherapy regimen to treat patients with relapsed or refractory multiple myeloma.